JSP Pharmaceutical Manufacturing Thailand PCL (JSPm)

Currency in THB
1.86
+0.02(+1.09%)
Closed·

JSPm Financial Summary

Key Ratios

P/E Ratio28.21
Price/Book0.9
Debt / Equity29.42%
Return on Equity-1.31%
Dividend Yield2.83%
EBITDA147.38M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of THB (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.06%
Dividend Yield
2.83%
Industry Median 4.20%
Annualised payout
0.05
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 13, 2025
EPS / Forecast
0.06 / --
Revenue / Forecast
266.98M / --
EPS Revisions
Last 90 days

FAQ

What were JSP Pharmaceutical Manufacturing Thailand PCL's earnings for the latest quarter?

The JSP Pharmaceutical Manufacturing Thailand PCL EPS (TTM) is 0.06. JSP Pharmaceutical Manufacturing Thailand PCL reported sales of 266.98, net income of 28.13, and EPS of 0.06 for the latest quarter.

What was JSP Pharmaceutical Manufacturing Thailand PCL's net income for the latest quarter?

JSP Pharmaceutical Manufacturing Thailand PCL's net income for the latest quarter was 28.13.

How did JSP Pharmaceutical Manufacturing Thailand PCL's performance compare year-over-year in the latest quarter?

The company's revenue moved from 230.11 in the previous quarter to 266.98 in the latest quarter, and net income moved from 7.49 to 28.13 compared to the previous quarter.

What is JSP Pharmaceutical Manufacturing Thailand PCL's net profit margin on a TTM basis?

JSP Pharmaceutical Manufacturing Thailand PCL's trailing twelve months (TTM) net profit margin is 0.53%.

How does JSP Pharmaceutical Manufacturing Thailand PCL's debt to equity ratio compare to industry standards?

JSP Pharmaceutical Manufacturing Thailand PCL's total debt-to-equity ratio is 29.42%.

What is JSP Pharmaceutical Manufacturing Thailand PCL's return on investment on a TTM basis?

JSP Pharmaceutical Manufacturing Thailand PCL's trailing twelve months (TTM) return on investment (ROI) is -1.31%.

Did JSP Pharmaceutical Manufacturing Thailand PCL gain or lose cash last quarter?

In the latest quarter, JSP Pharmaceutical Manufacturing Thailand PCL's net change in cash was 0.93 million.

What were JSP Pharmaceutical Manufacturing Thailand PCL's total assets and liabilities in the latest quarter?

As of the latest quarter, JSP Pharmaceutical Manufacturing Thailand PCL reported total assets of 1,343.31 million and total liabilities of 227.25 million.

How has JSP Pharmaceutical Manufacturing Thailand PCL's total revenue grown this year?

JSP Pharmaceutical Manufacturing Thailand PCL's total revenue was 230.11 in the previous quarter and 266.98 in the latest quarter.

What is JSP Pharmaceutical Manufacturing Thailand PCL's gross margin on a TTM basis?

JSP Pharmaceutical Manufacturing Thailand PCL's trailing twelve months (TTM) gross margin is 42.13%.

What was JSP Pharmaceutical Manufacturing Thailand PCL's revenue per share for the latest quarter?

JSP Pharmaceutical Manufacturing Thailand PCL's revenue per share for the latest quarter was 13.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.